glipiZIDE recall: Failed Dissolution
glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
Why was glipiZIDE recalled?
Failed Dissolution Specifications:
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 1012910, Exp Date: 04/30/2025
- Product
- glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
- Recalling firm
- Amerisource Health Services LLC
- Quantity
- 2,028 units (cartons of 30 individual unit doses)
- Distribution
- Nationwide in the USA
- Recall date
- January 22, 2025
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)